• Proprietary discoveries poised to overcome
    the technical, economic and political hurdles
    that have impeded universal access to life-saving
    mRNA vaccines and therapeutics
  • Enabling large-scale, low-cost, global production,
    distribution and administration
    of mRNA vaccines and therapeutics
  • Novel formulations that allow room-temperature drying, storage and reconstitution of mRNA with the potential for use with all vaccines and delivery methods
  • Our painless, thermostable and cost-saving VaxiPatchâ„¢ microarray skin patch accommodates both mRNA and adjuvanted subunit protein-based vaccines